Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Troshinsky, M. B.
space
  arrow  Castell, D. O.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Pulmonary Function and Gastroesophageal Reflux in Systemic Sclerosis

right arrow Matthew B. Troshinsky, MD; Gregory C. Kane, MD; John Varga, MD; Jacqueline R. Cater, PhD; James E. Fish, MD; Sergio A. Jimenez, MD; and Donald O. Castell, MD

1 July 1994 | Volume 121 Issue 1 | Pages 6-10

Objective: To determine the relations among esophageal dysfunction, gastroesophageal reflux, and lung involvement in patients with systemic sclerosis.

Design: Retrospective review of esophageal motility, esophageal pH, and pulmonary function data.

Setting: University hospital outpatient clinic and community.

Patients: 39 consecutively referred patients who were grouped according to the presence or absence of abnormal distal (pH <4.0 for >5% of the 24-hour monitoring period) or proximal (pH <4.0 for >1% of the 24-hour period) gastroesophageal acid reflux. Patients were also grouped according to the presence or absence of distal esophageal peristalsis.

Measurements: Esophageal manometry, dual-probe (distal and proximal) esophageal 24-hour pH measurements, and pulmonary function studies (forced vital capacity, forced expiratory volume at 1 second, total lung capacity, and single-breath carbon monoxide diffusing capacity [DLCO]).

Results: The mean total lung capacity (values as percentage predicted) was 87.1% ±11.2% (SD) for patients with abnormal proximal reflux and 77.8% ±21.6% for patients with normal proximal reflux (difference, 9.3%; 95% CI, –1.4% to 20.0%). The mean forced vital capacity for these patients was 91.1% ±12.4% and 85.4% ±25.6%, respectively (difference, 5.7%; CI, –6.9% to 18.1%). The mean total lung capacity was 83.8% ±15.4% for patients with abnormal distal reflux and 77.9% ±22.7% for patients with normal distal reflux (difference, 5.9%; CI, –7.6% to 19.4%). Among potential confounders of pulmonary measures, only smoking was related to decreased pulmonary function (smoking related to decreased DLCO P < 0.01). Smoking was more common in patients with abnormal distal reflux than in those with normal distal reflux (65% compared with 25%, P = 0.03). After adjusting for smoking, the difference in mean DLCO between patients with abnormal compared with normal distal reflux was 7.19% (CI, –8.5% to 22.9%).

Conclusion: Important measures of lung volume indicative of interstitial lung disease (total lung capacity, forced vital capacity) do not appear to be related to abnormal gastroesophageal acid reflux in patients with systemic sclerosis.

Author and Article Information
space

From Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; The Graduate Hospital, Philadelphia, Pennsylvania.
Requests for Reprints: Donald O. Castell, MD, Department of Medicine, The Graduate Hospital, 1800 Lombard Street, Suite 501, Pepper Pavilion, Philadelphia, PA 19146.
Acknowledgments: The authors thank Susan L. Georgeson, RN, MSN, Susie F. Denuna, and Debra Bruestle for their technical and secretarial assistance.
Grant Support: In part by grants AR42309 and AR19106 from the National Institutes of Health.







 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.